Senzime
Company Details
Status: Public
Employees: 101-250
Location:
Uppsala, Sweden
Type:
sample
sample
Technology:
sample
About: Senzime is a leading global medical device company, developing precision-based patient monitoring solutions that drive a global paradigm shift in perioperative patient safety. Our cutting-edge solutions TetraGraph and ExSpiron 2Xi are powered by proprietary, smart algorithms to monitor neuromuscular and respiratory functions during and after surgery.
With our dedicated team and strong partnerships, we are on a global mission to safeguard every patient's journey, from anesthesia to recovery.
Established in 1999, Senzime is backed by long-term investors and listed on the Nasdaq Stockholm Main Market (SEZI), with cross-trading on the New York OTCQX market (SNZZF).
#senzime #tetragraph #patientsafety #tofmonitoring #anesthesia
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Senzime | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.